期刊文献+

二甲双胍与克罗米芬治疗23例多囊卵巢综合征疗效分析 被引量:3

Clinical Analysis the Efficacy of Metformin Combined with Clomiphene in the Treatment of 23 Cases of Polycystic Ovary Syndrome
暂未订购
导出
摘要 目的:探讨二甲双胍与克罗米芬治疗多囊卵巢综合征的疗效。方法:随机选取诊断明确的多囊卵巢综合征患者44例,治疗组23例,给予二甲双胍与克罗米芬治疗,对照组21例,只给予克罗米芬治疗。结果:治疗组的排卵率83%和周期妊娠率24%与对照组(89%、17%)比较,差异无统计学意义(P>0.05),治疗组流产率4%与对照组10%比较,差异无统计学意义(P>0.05)。治疗组子宫内膜的厚度显著厚于克罗米芬组(P<0.05)。结论:二甲双胍与克罗米芬治疗多囊卵巢综合征不孕症的疗效尚有待探讨,目前对二甲双胍的适应证存在诸多分歧,但一般认为二甲双胍可作为一种辅助治疗。 Objective:To investigate the efficacy of metformin and clomiphene in the treatment of polycystic ovary syndrome.Methods:44 patients with polycystic ovary syndrome were randomly selected,the treatment group(23 cases)were given metformin and clomiphene,the control group(21 cases)were given only clomiphene.Results:The ovulation rate and pregnancy rates were 83% and 24% in treatment group,there were 89% and 17% in the control group,the difference was not statistically significant(P0.05).The abortion rate was 4% in treatment group and 10% in control group,the difference was not statistically significant(P0.05).The treatment group endometrial thickness was significantly thicker than the control group(P0.05).Conclusion:Metformin and clomiphene in treatment of polycystic ovary syndrome,infertility efficacy remains to be explored,there are many differences between the current use of metformin indications,but it generally believed that metformin can be used as an adjuvant therapy.
出处 《中外医学研究》 2012年第14期24-25,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 多囊卵巢综合征 二甲双胍 克罗米芬 Polycystic ovary syndrome Metformin Clomiphene
  • 相关文献

参考文献5

二级参考文献25

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3092
  • 2杨冬梓,陈晓莉.小儿和青春期妇科学中一个常见的问题—青春期多囊卵巢综合征[J].中国妇产科临床杂志,2005,6(6):403-405. 被引量:14
  • 3张利萍.阴道超声探头经直肠探查盆腔的临床应用[J].中国超声医学杂志,1996,12(10):57-58. 被引量:12
  • 4Boomsma CM,Eijkemans MJ,Hughes EG,et al.A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.Hum Reprod Update,2006,12(6):673-683.
  • 5Corbould A,Kin YB,Youngren JF,et al.Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.Am J Physiol Endocrinol Metab,2005,288(5):E1047-E1054.
  • 6Lord JM,Flight IH,Norman RJ.insulin-sensitisingdrugs(met-formin,troglitazone,rosiglitazone,pioglitazone D-chiro-inositol)for polycystic ovary syndrome.Cochrane Database SystRev,2003,(3):CD003053.
  • 7Brettentnthaler N,De Geyter C,Huber PR,et al.Effect of the insulin sensitizer pioglitazone on insulin resistance,hyperandrogenism,and ovulatory dysfunction in women with polycystic ovary syndrome.J Clin Endocrinol Metab,2004,89(8):3835-3840.
  • 8Tang T,Glanville J,Hayden CJ,et al.Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome.A randomized,placebo-controlled,double-blind multicentre study.Hum Reprod,2006,21(1):80-89.
  • 9Legro RS,Zaino RJ,Demers LM,et al.The effects of metformin and rosiglitazone,alone and in combination,on the ovary and endometrium in polycystic ovary syndrome.Am J Obstet Gynecol,2007,196(4):402 -410.
  • 10Rizzo M,Berneis K,Carmina E,et al.How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome.Am J Obstet Gynecol,2008,198(1):28 -35.

共引文献377

同被引文献33

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部